Deal value for PE-backed transactions actually increased during the first half of this year, according to data from Thomson Reuters.
That’s not the case with general M&A. So far this year, we’ve seen 3,627 U.S. announced mergers during the first half of 2012, valued at $333.9 billion, Thomson Reuters said. First half’s deal value dropped nearly 41% from the 4,339 transactions that totaled $565.7 billion for the same time period in 2011.
One of the year’s biggest deals is the sale of Pfizer Nutrition to Nestle for nearly $12 billion.
Private equity-backed M&A (which includes LBOs and acquisitions made by portfolio companies) wasn’t as depressing. In fact, deal value jumped by 5%. There were 688 deals valued at $56.3 billion during the first half of 2012, compared to 733 transactions totaling $53.6 billion, Thomson Reuters said. Some may scoff at this meager 5% increase, but with deals as slow as they are, I’ll take what I can get.
What were the biggest PE-backed deals so far this year? Well, you’ll have to read the rest to find out.
Photo courtesy of Shutterstock